Xeloda Sales Data
| Rank 97 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: May 2013 (updated quarterly).
The following data shows Xeloda U.S. retail sales in Q1 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q1 2013 | 97 ( 2) |
$174,526 | -2.21% | 59 | -9.23% |
| Q4 2012 | 95 | $178,469 | 1.16% | 65 |  |
| Q3 2012 | 95 ( 1) |
$176,414 | 5.28% | 65 | -1.52% |
| Q2 2012 | 96 ( ) |
$167,560 | |
66 | |
| Q4 2011 | 96 (5) |
$168,186 | 1.39% | 69 | |
| Q3 2011 | 91 () |
$165,875 | |
69 | |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
See Also
Related News
| Date | Article |
|---|---|
| June 9, 2011 | Chemo for Late-Stage Cancer Patients May Be Unjustified |
| May 13, 2009 | Chemotherapy Superior to New Drug for Early Breast Cancer |
